ONCOTARGET

Publications

  1. 2015
  2. Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion

    Lin, Y-N., Bhuwania, R., Gromova, K., Failla, A. V., Lange, T., Riecken, K., Linder, S., Kneussel, M., Izbicki, J. R. & Windhorst, S., 30.07.2015, In: ONCOTARGET. 6, 21, p. 18577-89 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Repressing the repressor: Fra1 controls plasma cell generation

    Mielenz, D., Grötsch, B. & David, J-P., 20.07.2015, In: ONCOTARGET. 6, 20, p. 17861-2 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  4. Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization

    Dyshlovoy, S. A., Hauschild, J., Amann, K., Tabakmakher, K. M., Venz, S., Walther, R., Guzii, A. G., Makarieva, T. N., Shubina, L. K., Fedorov, S. N., Stonik, V. A., Bokemeyer, C., Balabanov, S., Honecker, F. & Amsberg, G., 10.07.2015, In: ONCOTARGET. 6, 19, p. 17328-41 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Crosstalk of parkin and Ret in dopaminergic neurons

    Kramer, E. R., 30.06.2015, In: ONCOTARGET. 6, 18, p. 15704-5

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  6. Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies

    Gemoll, T., Epping, F., Heinrich, L., Fritzsche, B., Roblick, U. J., Szymczak, S., Hartwig, S., Depping, R., Bruch, H-P., Thorns, C., Lehr, S., Paech, A. & Habermann, J. K., 30.06.2015, In: ONCOTARGET. 6, 18, p. 16517-26 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  7. Heme oxygenase-1: for better, for worse, in sickness and in health

    Solano, M. E. & Arck, P. C., 20.06.2015, In: ONCOTARGET. 6, 17, p. 14733-4 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  8. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

    Stückrath, I., Rack, B., Janni, W., Jäger, B., Pantel, K. & Schwarzenbach, H., 30.05.2015, In: ONCOTARGET. 6, 15, p. 13387-401 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma

    Kumar, P., Nandi, S., Tan, T. Z., Ler, S. G., Chia, K. S., Lim, W-Y., Bütow, Z., Vordos, D., De la Taille, A., Al-Haddawi, M., Raida, M., Beyer, B., Ricci, E., Colombel, M., Chong, T. W., Chiong, E., Soo, R., Park, M. K., Ha, H. K., Gunaratne, J. & Thiery, J. P., 30.05.2015, In: ONCOTARGET. 6, 15, p. 13539-49 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair

    Srinivas, U. S., Dyczkowski, J., Beißbarth, T., Gaedcke, J., Mansour Khalfallah, W. Y., Borgmann, K. & Dobbelstein, M., 20.05.2015, In: ONCOTARGET. 6, 14, p. 12574-86 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer

    Braig, F., März, M., Schieferdecker, A., Schulte, A., Voigt, M., Stein, A., Grob, T., Alawi, M., Indenbirken, D., Kriegs, M., Engel, E., Vanhoefer, U., Grundhoff, A., Loges, S., Riecken, K., Fehse, B., Bokemeyer, C. & Binder, M., 20.05.2015, In: ONCOTARGET. 6, 14, p. 12035-47 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis

    Stoyanov, E., Ludwig, G., Mizrahi, L., Olam, D., Schnitzer-Perlman, T., Tasika, E., Sass, G., Tiegs, G., Jiang, Y., Nie, T., Kohler, J., Schinazi, R. F., Vertino, P. M., Cedar, H., Galun, E. & Goldenberg, D., 10.05.2015, In: ONCOTARGET. 6, 13, p. 11047-60 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

    Mock, A., Warta, R., Geisenberger, C., Bischoff, R., Schulte, A., Lamszus, K., Stadler, V., Felgenhauer, T., Schichor, C., Schwartz, C., Matschke, J., Jungk, C., Ahmadi, R., Sahm, F., Capper, D., Glass, R., Tonn, J-C., Westphal, M., von Deimling, A., Unterberg, A., Bermejo, J. L. & Herold-Mende, C., 12.04.2015, In: ONCOTARGET. 6, 15, p. 13576-13590

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

    Zabalza, C. V., Adam, M., Burdelski, C., Wilczak, W., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Koop, C., Hube-Magg, C., Graefen, M., Heinzer, H., Minner, S., Simon, R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 23.03.2015, In: ONCOTARGET. 6, 14, p. 12822-12834

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs

    Ben-Batalla, I., Cubas-Cordova, M., Udonta, F., Wroblewski, M., Waizenegger, J. S., Janning, M., Sawall, S., Gensch, V., Zhao, L., Martinez-Zubiaurre, I., Riecken, K., Fehse, B., Pantel, K., Bokemeyer, C. & Loges, S., 20.03.2015, In: ONCOTARGET. 6, 8, p. 6341-58 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    Burdelski, C., Strauss, C., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Krech, T., Sauter, G., Wilczak, W., Simon, R., Schlomm, T. & Steurer, S., 25.02.2015, In: ONCOTARGET.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. The landscape of metastatic progression patterns across major human cancers

    Budczies, J., von Winterfeld, M., Klauschen, F., Bockmayr, M., Lennerz, J. K., Denkert, C., Wolf, T., Warth, A., Dietel, M., Anagnostopoulos, I., Weichert, W., Wittschieber, D. & Stenzinger, A., 01.01.2015, In: ONCOTARGET. 6, 1, p. 570-83 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2014
  19. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver

    Ella, E., Heim, D., Stoyanov, E., Harari-Steinfeld, R., Steinfeld, I., Pappo, O., Perlman, T. S., Nachmansson, N., Rivkin, L., Olam, D., Abramovitch, R., Wege, H., Galun, E. & Goldenberg, D., 15.11.2014, In: ONCOTARGET. 5, 21, p. 10318-10331 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients

    Eichelser, C., Stückrath, I., Müller, V., Milde-Langosch, K., Wikman-Kocher, H., Pantel, K. & Schwarzenbach, H., 30.10.2014, In: ONCOTARGET. 5, 20, p. 9650-63 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL

    Schieferdecker, A., Voigt, M., Riecken, K., Braig, F., Schinke, T., Loges, S., Bokemeyer, C., Fehse, B. & Binder, M., 30.08.2014, In: ONCOTARGET. 5, 16, p. 6647-53 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia

    Frietsch, J. J., Kastner, C., Grunewald, T. G. P., Schweigel, H., Nollau, P., Ziermann, J., Clement, J. H., La Rosée, P., Hochhaus, A. & Butt, E., 30.07.2014, In: ONCOTARGET. 5, 14, p. 5257-71 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients

    Wikman-Kocher, H., Westphal, L., Schmid, F., Pollari, S., Kropidlowski, J., Sielaff-Frimpong, B., Glatzel, M., Matschke, J., Westphal, M., Iljin, K., Huhtala, H., Terracciano, L., Kallioniemi, A., Sauter, G., Müller, V., Witzel, I., Lamszus, K., Kemming, D. & Pantel, K., 16.03.2014, In: ONCOTARGET. 5, 10, p. 3076-3087

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue

    David, K. A., Unger, F. T., Uhlig, P., Juhl, H., Moore, H. M., Compton, C., Nashan, B., Dörner, A., de Weerth, A. & Zornig, C., 2014, In: ONCOTARGET. 5, 22, p. 11017-28 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. 2013
  26. Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival

    Wagner, J. Y., Schwarz, K., Schreiber, S., Schmidt, B., Wester, H-J., Schwaiger, M., Peschel, C., von Schilling, C., Scheidhauer, K. & Keller, U., 01.06.2013, In: ONCOTARGET. 4, 6, p. 899-910 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition

    Mohan, P., Castellsague, J., Jiang, J., Allen, K., Chen, H., Nemirovsky, O., Spyra, M., Hu, K., Kluwe, L., Pujana, M. A., Villanueva, A., Mautner, V-F., Keats, J. J., Dunn, S. E., Lazaro, C. & Maxwell, C. A., 01.01.2013, In: ONCOTARGET. 4, 1, p. 80-93 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2012
  29. Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108].

    Szepeshazi, K., Schally, A. V., Keller, G., Block, N. L., Benten, D., Halmos, G., Szalontay, L., Vidaurre, I., Jaszberenyi, M. & Rick, F. G., 2012, In: ONCOTARGET. 3, 7, p. 686-699 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 3 Next